Daesung Microbiological Labs. Co., Ltd. (036480.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩5,510 (+0.00%) as of
Key statistics
- Market cap
- 20.94B
- Dividend yield
- 1.36%
- 52-week range
- 5,400.00 – 10,960.00
- Beta
- 0.07
- Revenue (TTM)
- 25.2B
- Profit margin
- 1.39%
- Volume
- 2.40k
About Daesung Microbiological Labs. Co., Ltd.
Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Uiwang-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.